NovoSeven

Human medicines European public assessment report (EPAR): Myozyme, alglucosidase alfa, Date of authorisation: 28/03/2006, Revision: 31, Status: Authorised

Human medicines European public assessment report (EPAR): Insulin lispro Sanofi, insulin lispro, Date of authorisation: 19/07/2017, Revision: 10, Status: Authorised

Human medicines European public assessment report (EPAR): Granupas (previously Para-aminosalicylic acid Lucane), para-aminosalicylic acid, Date of authorisation: 07/04/2014, Revision: 13, Status: Authorised

Human medicines European public assessment report (EPAR): Baraclude, entecavir, Date of authorisation: 26/06/2006, Revision: 29, Status: Authorised

Guide to CTIS training material catalogue

Clinical Trial Information System (CTIS) - Sponsor handbook

Sponsors' guide: Transition of trials from EudraCT to CTIS - CTIS Training Programme - Module 23

FAQs: Transition of trials from EudraCT to CTIS - CTIS Training Programme - Module 23

FAQs: Supervise a Clinical Trial: Ad Hoc Assessment - CTIS Training Programme - Module 17